0.4180EUR-2.68%Mkt Cap: 205.34M EURP/E: —Last update: 2026-05-14
Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy developm…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-5.32
PEG—
P/B2.70
P/S35.32
EV/EBITDA-5.34
EV/Revenue27.37
EPS (TTM)-0.10
EPS (Forward)-0.07
Cash Flow & Leverage
FCF Yield-8.46%
FCF Margin-298.79%
Operating CF-27.28M EUR
CapEx (TTM)756.00K EUR
Net Debt/EBITDA1.55
Net Debt-46.22M EUR
Technical
SMA 500.4359 (-4.1%)
SMA 2000.3571 (+17.1%)
Beta0.36
S&P 52W Chg24.23%
Avg Vol (30d)2.21M
Avg Vol (10d)2.40M
Technical Indicators
RSI (14)52.5
MACD0.0045
MACD Signal-0.0017
MACD Hist.+0.0062
BB Upper0.4410 EUR
BB Middle0.3972 EUR
BB Lower0.3534 EUR
BB Width22.07%
ATR (14)0.0382 EUR
Vol Ratio (20d)0.93x
52W Range
0.273027% of range0.8080
52W High0.8080 EUR
52W Low0.2730 EUR
Profitability
Gross Margin100.00%
EBITDA Margin0.00%
Profit Margin0.00%
Oper. Margin-399.80%
ROE-66.16%
ROA-50.84%
Revenue Growth5.00%
Earnings Growth—
Balance Sheet
Debt/Equity0.03
Current Ratio4.59
Quick Ratio4.53
Book Value/Sh0.1480 EUR
Cash/Share0.0920 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.514.63M
Float300.41M
Insiders34.81%
Institutions36.53%
Analyst Consensus
Rating—
Target (Mean)1.302 EUR
Target Range1.000 EUR – 2.000 EUR
# Analysts4
Company
Market Cap205.34M EUR
Enterprise Value159.15M EUR
Revenue (TTM)5.81M EUR
Gross Profit5.81M EUR
Net Income (TTM)-29.43M EUR
Revenue/Share0.0190 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees63
Last Price0.4180 EUR
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0012596468